You are here
The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.
SBC: CFD Research Corporation Topic: CBD10103
Current drug discovery and development efforts are severely limited by expensive animal trials and oversimplified in vitro models. Results obtained from in vitro models are not predictive of in vivo toxicity owing to significant difference from the in vivo physiological conditions. In this context, we propose to develop and demonstrate a novel microfluidic device that reproduces the physiological ...SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
SBC: CFD Research Corporation Topic: CBD10107
Current high-throughput platforms rely on labeled substrates that produce detectable spectroscopic signals upon reaction for monitoring enzyme catalytic activity. Add to that the high price tag for these instruments, ranging from several hundred thousand to millions of dollars, and there is a clear need for alternate solutions for a label-free, low-cost, high-throughput enzyme screening platform. ...SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
SBC: MORGAN RESEARCH CORP. Topic: CBD02300
This Phase II SBIR proposal is for the development of a miniaturized real-time visible/UV spectrometer prototype based on micro-opto-electro-mechanical systems (MOEMS) technology. Use of MOEMS technology enables orders of magnitude reductions in size, weSBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense